Journals / Hipokrat Tıp Dergisi / 2022 / Cilt: 2 - Sayı: 1

Promising New Target in the Treatment of Diseases: FOXO Transcription Factors

Hastalıkların Tedavisinde Umut Vadeden Yeni Hedef: FOXO Transkripsiyon Faktörleri

Pages
25–32
Publication Date
2022-04-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study; In order to present new research ideas to scientists, the definition and classification of FOXO transcription factors, post-transcriptional FOXO modifications under various physiological and pathophysiological conditions, including oxidative stress and cancer, and the clinical use of FOXO's tumor suppressor properties as therapeutics were investigated and compiled in the light of literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cells have evolved elaborate mechanisms to survive or coordinate the cellular response to apoptosis.
📊
Key Findings & Data:Forkhead box-O transcription factors (FOXOs); It plays critical roles in the execution of various cellular processes by regulating the expression of genes involved in DNA damage repair, cell cycle progression and arrest, oxidative stress response and redox signaling, gluconeogenesis and apoptosis.
💡
Conclusion & Impact:In this study; In order to present new research ideas to scientists, the definition and classification of FOXO transcription factors, post-transcriptional FOXO modifications under various physiological and pathophysiological conditions, including oxidative stress and cancer, and the clinical use of FOXO's tumor suppressor properties as therapeutics were investigated and compiled in the light of literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:FOXO · HASTALIK · İLAÇ

Abstract

Cells have evolved elaborate mechanisms to survive or coordinate the cellular response to apoptosis. Forkhead box-O transcription factors (FOXOs); It plays critical roles in the execution of various cellular processes by regulating the expression of genes involved in DNA damage repair, cell cycle progression and arrest, oxidative stress response and redox signaling, gluconeogenesis and apoptosis. Function of FOXO transcription factors; It is tightly controlled by post-translational modifications such as phosphorylation, acetylation and ubiquitination, and nuclear cytoplasmic transition. Made works; It shows that the regulatory effect of FOXO activity occurs in response to different stimuli, including oxidative stress. Abnormalities in post-transcriptional modification of FOXO transcription factors are frequently associated with various disease states. In this study; In order to present new research ideas to scientists, the definition and classification of FOXO transcription factors, post-transcriptional FOXO modifications under various physiological and pathophysiological conditions, including oxidative stress and cancer, and the clinical use of FOXO's tumor suppressor properties as therapeutics were investigated and compiled in the light of literature.

Özet

Hücreler, hayatta kalmak veya apoptozun hücresel cevabını koordine edebilmek için ayrıntılı mekanizmalar geliştirmiştir. Forkhead box-O transkripsiyon faktörleri (FOXO); DNA hasar onarımı, hücre döngüsü ilerlemesi ve durdurulması, oksidatif stres tepkisi ve redoks sinyali, glukoneogenez ve apoptoz ile ilgili genlerin ekspresyonunu düzenleyerek çeşitli hücresel süreçlerin yürütülmesinde kritik rol oynamaktadır. FOXO transkripsiyon faktörlerinin fonksiyonu; fosforilasyon, asetilasyon ve ubiküitinasyon gibi translasyon sonrası modifikasyonlar ve nükleer sitoplazmik geçiş ile sıkı bir şekilde kontrol edilmektedir. Yapılan çalışmalar; FOXO aktivitesinin düzenleyici etkisinin, oksidatif stres dahil olmak üzere farklı uyaranlara yanıt olarak oluştuğunu göstermektedir. FOXO transkripsiyon faktörlerinin transkripsiyon sonrası modifikasyonundaki anormallikler sıklıkla çeşitli hastalık durumlarıyla bağlantılıdır. Bu çalışmada, bilim insanlarına yeni araştırma fikirleri sunmak amacıyla FOXO transkripsiyon faktörleri’ nin tanımı ve sınıflandırılması, oksidatif stres ve kanser dahil olmak üzere çeşitli fizyolojik ve patofizyolojik koşullar altında transkripsiyon sonrası FOXO modifikasyonları ve FOXO' ların tümör baskılayıcı özelliklerinin terapötik olarak klinik kullanımı literatür bilgisi ışığında araştırılarak derlendi.

🔖

Cite This Article

VURANOK, N. (2022). Promising New Target in the Treatment of Diseases: FOXO Transcription Factors. Hipokrat Tıp Dergisi, Cilt: 2 - Sayı: 1, 25–32. https://ajindex.com/articles/852238

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Referans1. Kaestner KH, Knochel W, & Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes & development, 2000; 14(2), 142–146
  2. Referans2. Lee S, Dong HH. FoxO integration of insulin signaling with glucose and lipid metabolism. The Journal of endocrinology, 2017; 233(2), R67–R79
  3. Referans3. Brown AK, Webb AE. Regulation of FOXO Factors in Mammalian Cells. Current topics in developmental biology, 2018; 127, 165–192
  4. Referans4. Lu H, & Huang, H. FOXO1: a potential target for human diseases. Current drug targets, 2011; 12(9), 1235–1244
  5. Referans5. Webb AE, Pollina EA, Vierbuchen T, Urbán N, et al. FOXO3 shares common targets with ASCL1 genome-wide and inhibits ASCL1-dependent neurogenesis. Cell reports, 2013; 4(3), 477–491
  6. Referans6. Huang H, Tindall J. Dynamic FoxO transcription factors. J Cell Sci, 2007; 120 (15): 2479–2487
  7. Referans7. Wang Z, Yu T, Huang P. Post-translational modifications of FOXO family proteins (Review). Molecular medicine reports, 2016; 14(6), 4931–4941
  8. Referans8. Wang F, Chan CH, Chen K, Guan X, et al. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation. Oncogene, 2012; 31(12), 1546–1557
  9. Referans9. Zhang J, Zhong Q. Histone deacetylase inhibitors and cell death. Cell Mol Life Sci. 2014; 71(20): 3885–3901
  10. Referans10. Klotz LO, Sánchez-Ramos C, Prieto-Arroyo L; Urbánek P, et al. Redox regulation of FoxO transcription factors. Redox Biology, 2015; 6, 51–72. doi:10.1016/j.redox.2015.06.019
  11. Referans11. Shen M, Cao Y, Jiang Y, Wei Y, et al. Melatonin protects mouse granulosa cells against oxidative damage by inhibiting FOXO1-mediated autophagy: Implication of an antioxidation-independent mechanism. Redox biology,2018; 18, 138–157
  12. Referans12. O'Neill BT, Bhardwaj G, Penniman CM, Krumpoch MT, et al. FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy. Diabetes, 2019; 68(3), 556–570
  13. Referans13. Peng SL. Foxo in the immune system. Oncogene, 2008; 27(16), 2337–2344
  14. Referans14. Brunet A, Sweeney LB, Sturgill JF, Chua KF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science (New York, N.Y.), 2004; 303(5666), 2011–2015
  15. Referans15. Lu M, Wan M, Leavens KF, Chu Q, et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nature medicine, 2012; 18(3), 388–395
  16. Referans16. Wang D, Wang T, Wang